Appendix B: Panel Roster and Financial Disclosures
Invasive Mycoses
Member | Institution | Financial Disclosure | |
---|---|---|---|
Company | Relationship | ||
John Baddley | University of Maryland School of Medicine | Synexis | Research Support (paid to institution) |
David Boulware | University of Minnesota Medical School | Appili Therapeutics Matinas BioPharma | Research Support (paid to institution) |
Marisa Miceli | University of Michigan Medical School | SCYNEXIS F2G Mayne Pharma | Research Support (paid to institution) |
SCYNEXIS | Data Safety Monitoring Board | ||
Astellas Pharma | Consulting | ||
John Perfect* | Duke University, School of Medicine | Pfizer | Advisory Board |
George R. Thompson | University of California, Davis Medical Center | Amplyx Pharmaceuticals Astellas Pharm Cidara Therapeutics F2G Mayne Pharma | Scientific Advisory Board |
* Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
Download Guidelines
- Section Only PDF (16.83 KB)
- Full Guideline PDF (6.03 MB)
- Tables Only PDF (1.18 MB)